The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

But 25-year-old Madison Burgess has thrown caution to the wind by opting to micro-dose the drug. The Michigan native revealed ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Madison Burgess, a Michigan native, achieved significant weight loss with Ozempic after struggling with conventional methods.

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

The diabetes medication Ozempic has emerged as an unexpected player in the weight loss arena, sparking intense ...

“We would not be able to say for certain that a patient is reaping the full potential benefits of GLP-1 medications that have ...

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...